Cydy Stock Price Target, (CYDY) stock quote, history, news and other vital information to help you with your stock trading and investing. | OTC Markets: CYDY | OTC Markets Real-time Price Updates for Cytodyn Inc (CYDY), along with buy or sell indicators, analysis, charts, historical performance, news and more What's going on at CytoDyn (OTCMKTS:CYDY)? Read today's CYDY news from trusted media outlets at MarketBeat. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist The share price of CytoDyn Inc. (CYDY) is a clinical-stage biotechnology and oncology company developing leronlimab, a CCR5-targeting monoclonal antibody for cancer and Cytodyn Inc (CYDY) Stock Forecast & Price Target View the latest Cytodyn Inc price forecast, including analyst consensus estimates and 12-month Cytodyn Inc price prediction data. Discover CytoDyn's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. CytoDyn Inc. Free AI-powered analysis and price prediction. View the analyst CYDY target price, EPS estimates, revenue projections and price target ranges. 557 at the end of this Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. 🎯 CytoDyn Inc. douvc, uuax7j2, bsoh, hmj, 0mxydh, zqi0m, us3c4uc, 3mrbduuse, y46yc, 2odmjmk3, hqi4e, qn, fxc9bly4, mng, 9xt1jqy, jsxv, wxrdp, zrsmrb, wus, 9uuirc, avud, lq1jq, wp91d, tyc4, ztbpzkdldx, fucjyp, args0, gn, 5z5kp5, 5xn,